Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Invested Capital (2016 - 2026)

Cumberland Pharmaceuticals' Invested Capital history spans 16 years, with the latest figure at $24.5 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 12.2% to $24.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.5 million, a 12.2% decrease, with the full-year FY2025 number at $24.5 million, down 12.2% from a year prior.
  • Invested Capital hit $24.5 million in Q4 2025 for Cumberland Pharmaceuticals, down from $26.1 million in the prior quarter.
  • Over the last five years, Invested Capital for CPIX hit a ceiling of $47.8 million in Q2 2021 and a floor of $24.5 million in Q4 2025.
  • Historically, Invested Capital has averaged $34.7 million across 5 years, with a median of $35.8 million in 2022.
  • Biggest five-year swings in Invested Capital: decreased 29.33% in 2024 and later increased 6.33% in 2025.
  • Tracing CPIX's Invested Capital over 5 years: stood at $42.6 million in 2021, then decreased by 15.56% to $36.0 million in 2022, then dropped by 18.66% to $29.3 million in 2023, then fell by 4.46% to $28.0 million in 2024, then dropped by 12.2% to $24.5 million in 2025.
  • Business Quant data shows Invested Capital for CPIX at $24.5 million in Q4 2025, $26.1 million in Q3 2025, and $27.7 million in Q2 2025.